Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base
Yıl: 2020 Cilt: 21 Sayı: 4 Sayfa Aralığı: 283 - 284 Metin Dili: İngilizce DOI: 10.5152/TurkThoracJ.2020.20.03 İndeks Tarihi: 19-10-2020
Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editoryal Erişim Türü: Erişime Açık
- 1. World Health Organization. COVID-19 Situation Dashboard. Available from: URL. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd
- 2. 2. TC Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü. Available from: URL: https://covid19.saglik.gov.tr/
- 3. World Health Organization. COVID-19 Situation Report. Available from: URL: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200327-sitrep-67-covid-19.pdf?sfvrsn=b65f68eb_4
- 4. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. COVID-19 (SARS-CoV2 Enfeksiyonu) Rehberi (Bilim Kurulu Çalışması) 25 Mart 2020. www.hsgm.saglik.gov.tr
- 5. Agrawal S, Gupta N, Goel AD. Evidence based treatment of SARS-CoV2 - A narrative review. Turk Thorac J 2020;21(3):221-2. [Crossref]
- 6. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020.
- 7. Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020. [Crossref]
- 8. Wu X, Cai Y, Huang X, et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis 2020. [Crossref]
| APA | Sayiner A (2020). Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base. , 283 - 284. 10.5152/TurkThoracJ.2020.20.03 |
| Chicago | Sayiner Abdullah Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base. (2020): 283 - 284. 10.5152/TurkThoracJ.2020.20.03 |
| MLA | Sayiner Abdullah Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base. , 2020, ss.283 - 284. 10.5152/TurkThoracJ.2020.20.03 |
| AMA | Sayiner A Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base. . 2020; 283 - 284. 10.5152/TurkThoracJ.2020.20.03 |
| Vancouver | Sayiner A Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base. . 2020; 283 - 284. 10.5152/TurkThoracJ.2020.20.03 |
| IEEE | Sayiner A "Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base." , ss.283 - 284, 2020. 10.5152/TurkThoracJ.2020.20.03 |
| ISNAD | Sayiner, Abdullah. "Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base". (2020), 283-284. https://doi.org/10.5152/TurkThoracJ.2020.20.03 |
| APA | Sayiner A (2020). Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base. Turkish Thoracic Journal, 21(4), 283 - 284. 10.5152/TurkThoracJ.2020.20.03 |
| Chicago | Sayiner Abdullah Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base. Turkish Thoracic Journal 21, no.4 (2020): 283 - 284. 10.5152/TurkThoracJ.2020.20.03 |
| MLA | Sayiner Abdullah Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base. Turkish Thoracic Journal, vol.21, no.4, 2020, ss.283 - 284. 10.5152/TurkThoracJ.2020.20.03 |
| AMA | Sayiner A Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base. Turkish Thoracic Journal. 2020; 21(4): 283 - 284. 10.5152/TurkThoracJ.2020.20.03 |
| Vancouver | Sayiner A Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base. Turkish Thoracic Journal. 2020; 21(4): 283 - 284. 10.5152/TurkThoracJ.2020.20.03 |
| IEEE | Sayiner A "Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base." Turkish Thoracic Journal, 21, ss.283 - 284, 2020. 10.5152/TurkThoracJ.2020.20.03 |
| ISNAD | Sayiner, Abdullah. "Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base". Turkish Thoracic Journal 21/4 (2020), 283-284. https://doi.org/10.5152/TurkThoracJ.2020.20.03 |
